CpG oligodeoxynucleotides activate HIV replication in latently infected human T cells (Q38343698)

2 September 2017

title

CpG oligodeoxynucleotides activate HIV replication in latently infected human T cells (English)

1 reference

2 September 2017

13

Ulf Dittmer

1 reference

2 September 2017

10

Volker ter Meulen

1 reference

2 September 2017

Carsten Scheller

1

1 reference

2 September 2017

Anett Ullrich

2

1 reference

2 September 2017

Kirsty McPherson

3

1 reference

2 September 2017

Barbara Hefele

4

1 reference

2 September 2017

Johanna Knöferle

5

1 reference

2 September 2017

Stefan Lamla

6

1 reference

2 September 2017

Anke R M Olbrich

7

1 reference

2 September 2017

Hartmut Stocker

8

1 reference

2 September 2017

Keikawus Arasteh

9

1 reference

2 September 2017

Axel Rethwilm

11

1 reference

2 September 2017

Eleni Koutsilieri

12

1 reference

2 September 2017

language of work or name

English

0 references

publication date

11 March 2004

1 reference

Journal of Biological Chemistry

2 September 2017

published in

1 reference

2 September 2017

volume

279

1 reference

2 September 2017

issue

21

1 reference

2 September 2017

page(s)

21897-21902

1 reference

CpG motifs in bacterial DNA trigger direct B-cell activation

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311609200

CpG motifs in bacterial DNA and their immune effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311609200

Poly-guanosine motifs costimulate antigen-reactive CD8 T cells while bacterial CpG-DNA affect T-cell activation via antigen-presenting cell-derived cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311609200

A Toll-like receptor recognizes bacterial DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311609200

Innate immune recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311609200

Cutting edge: Role of Toll-like receptor 9 in CpG DNA-induced activation of human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311609200

Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311609200

Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311609200

CpG DNA as a Th1-promoting adjuvant in immunization against Trypanosoma cruzi

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311609200

Vaccination with DNA containing tat coding sequences and unmethylated CpG motifs protects cynomolgus monkeys upon infection with simian/human immunodeficiency virus (SHIV89.6P).

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311609200

Immunostimulatory CpG motifs trigger a T helper-1 immune response to human immunodeficiency virus type-1 (HIV-1) gp 160 envelope proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311609200

Effective postexposure treatment of retrovirus-induced disease with immunostimulatory DNA containing CpG motifs

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311609200

Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311609200

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311609200

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311609200

Recovery of Replication-Competent HIV Despite Prolonged Suppression of Plasma Viremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311609200

Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311609200

Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311609200

Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311609200

Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311609200

Induction of HIV-1 replication in latently infected CD4+ T cells using a combination of cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311609200

Latent reservoirs of HIV: obstacles to the eradication of virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311609200

Immuno-activation with anti-CD3 and recombinant human IL-2 in HIV-1-infected patients on potent antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311609200

Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311609200

Characterization of a continuous T-cell line susceptible to the cytopathic effects of the acquired immunodeficiency syndrome (AIDS)-associated retrovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311609200

Bacterial DNA activates human neutrophils by a CpG‐independent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311609200

Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311609200

Immunostimulatory CpG oligodeoxynucleotides stimulate expression of IL-1beta and interferon-like cytokines in rainbow trout macrophages via a chloroquine-sensitive mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311609200

Lipopolysaccharide and CpG DNA synergize for tumor necrosis factor-alpha production through activation of NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311609200

CpG DNA rescues B cells from apoptosis by activating NFkappaB and preventing mitochondrial membrane potential disruption via a chloroquine-sensitive pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311609200

Toll-Like Receptor 2 (TLR2) and TLR9 Signaling Results in HIV-Long Terminal RepeatTrans-Activation and HIV Replication in HIV-1 Transgenic Mouse Spleen Cells: Implications of Simultaneous Activation of TLRs on HIV Replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311609200

The effect of acute infectious illnesses on plasma human immunodeficiency virus (HIV) type 1 load and the expression of serologic markers of immune activation among HIV-infected adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311609200

Effect of coinfection with STDs and of STD treatment on HIV shedding in genital-tract secretions: systematic review and data synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311609200

Preinfection treatment of resistant mice with CpG oligodeoxynucleotides renders them susceptible to friend retrovirus-induced leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311609200

Re-emergence of HIV after stopping therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311609200

Activation of HIV gene expression during monocyte differentiation by induction of NF-kB

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311609200

21 January 2018

Identifiers

DOI

10.1074/JBC.M311609200

1 reference

2 September 2017

1 reference